: FDA warns three baby-formula makers about production violations

The FDA Wednesday sent warning letters to three baby-formula makers as part of what the agency called enhanced oversight of a product plagued by recalls and shortages.

Previous post Dow Jones Newswires: Canopy Growth amends agreement to buy remaining stake of Les Serres Vert Cannabis
Next post Earnings Watch: Chewy says customers are becoming more ‘discerning,’ but shares rally on surprise profit